Label at a glance#

ProductThiosinaminum

Active ingredientALLYLTHIOUREA

Label structure8 sections

Indications and uses

To relieve the symptoms of scarring.

Dosage and administration

Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

THIOSINAMINUM

USES

OTC - PURPOSE SECTION

To relieve the symptoms of scarring.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children.

INDICATIONS

INDICATIONS & USAGE SECTION

Indications:

THIOSINAMINUM Scarring

STOP USE AND ASK DOCTOR

WARNINGS SECTION

If symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Sucrose/Lactose

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Enter section text The OTC potency range of THIOSINAMINUM is 3x–30x, 2c–30c, 200c, 1m, 10m, 50m, and CM.

Availability is subject to change.

Thiosinaminum2023

All WHP single remedies are made to order; thus, the labels are printed on the same label stock as the orders are filled.

‘Bottle Size’ and ‘Potency’ vary on the label depending on customer choice.

Standard bottle sizes for pellet-form remedies are 2 dram, 4 dram, 1 ounce, 2 ounce, and 4 ounce.

here

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68428-674-03	2025-01-30	C162847	48780-1	2cef2736-76e8-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-674-05	2025-01-30	C162847	48780-1	2cef2736-76e8-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-674-06	2025-01-30	C162847	48780-1	2cef2736-76e8-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-674-11	2025-01-30	C162847	48780-1	2cef2736-76e8-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-674-12	2025-01-30	C162847	48780-1	2cef2736-76e8-d83d-e063-dadaa90ab31f	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68428-674-03	Thiosinaminum	75 in 1 VIAL, GLASS	PELLET	75	3
68428-674-05	Thiosinaminum	150 in 1 VIAL, GLASS	PELLET	150	3
68428-674-06	Thiosinaminum	1200 in 1 BOTTLE, GLASS	PELLET	1200	3
68428-674-11	Thiosinaminum	300 in 1 BOTTLE, GLASS	PELLET	300	3
68428-674-12	Thiosinaminum	600 in 1 BOTTLE, GLASS	PELLET	600	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68428-674	THIOSINAMINUM (ALLYLTHIOUREA) PELLET [WASHINGTON HOMEOPATHIC PRODUCTS]	3	Legacy NDC, 5 package rows	20231021_454fc826-c4ce-4a21-9382-930c8dcfc2fc.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

Thiosinaminum
ALLYLTHIOUREA
SUCROSE
LACTOSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68428-674	68428-674-03, 68428-674-05, 68428-674-11, 68428-674-12, 68428-674-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
LACTOSE	J2B2A4N98G	IACT
ALLYLTHIOUREA	706IDJ14B7	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
082856c9-a018-3b54-e063-6394a90af3c3			454fc826-c4ce-4a21-9382-930c8dcfc2fc	2023-10-20	Warnings	Exact identifier spl id: 082856c9-a018-3b54-e063-6394a90af3c3 spl set id: 454fc826-c4ce-4a21-9382-930c8dcfc2fc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.